News and insights

OVER €30 MILLION FOR THE BIOTECH PROJECT: THE FUTURE IS NOW!

Researcher conducting a laboratory experiment for the Biotech project

The presentation of the Capitanata Development Programme “Biotech Platform” will be held on Saturday 18 September at 17:00 at the Confindustria Foggia headquarters, Via Valentini Vista Franco 1, Sala Fantini.

Speakers will include the Rector of the University of Foggia, Prof. Pierpaolo Limone; the Coordinator of the MIT Technical Mission Unit, Prof. Giuseppe Catalano; the Director General of Casa Sollievo della Sofferenza, Dr Michele Giuliani; and the Vice-President of the Puglia Region, Raffaele Piemontese.
In video link, the President of the Puglia Region, Dr. Michele Emiliano.
The illustrative report will be carried out by the Director General of PST Technoscience, Eng. Stefano Di Rosa, who is Project Manager of the Development Programme.

The important meeting will end with the formal signing of the Memorandum of Understanding between Confindustria Foggia and PST Technoscience.
The project, which involves an investment of over 30 million euros, will see the best skills in the Foggia area act in a network to industrially develop services to pharmaceutical companies, especially in the enormously developing nutraceutical sector.
Key participants will include Casa Sollievo della Sofferenza, the Technoscience Technology Park and the University of Foggia.

With kind regards, the President of Confindustria Foggia and the Executive Vice-President of the Technoscience Science and Technology Park are pleased to invite you.Biotech project visual on more than €30 million for research and innovation

How we turn ideas into projects

From initial assessment to validation: a collaborative method that turns knowledge, technologies and business needs into concrete initiatives.

01

Discovery and assessment

We start from the need, the scientific result or the available technology. We assess objectives, maturity, data, constraints and opportunities to define an initial realistic pathway.

02

Expertise and project design

We connect scientific and industrial partners and define activities, milestones, responsibilities and funding sources aligned with the expected outcome.

03

Validation and impact

We support experimentation, technology transfer and valorisation, measuring results and preparing the solution for its next step: adoption, partnership or market.

Related articles

Choose Technoscience!

To rapidly assess a project in biotech and translational medicine - from oncology and neuroscience to precision cardiology and telemedicine - we ask for: a clear clinical or industrial question, the available evidence (including negative findings), access to data and samples where applicable, a draft protocol (including ethical aspects), and hypotheses on biomarkers and endpoints. In return, we offer technical and scientific due diligence, the design of a credible TRL pathway and, where appropriate, support with regulatory strategy, validation and scalability.

Contatti biotech: professionisti pronti alla collaborazione e innovazione